AU683423B2 - Subcutaneous implants based on nomegestrol derivatives - Google Patents

Subcutaneous implants based on nomegestrol derivatives Download PDF

Info

Publication number
AU683423B2
AU683423B2 AU48229/93A AU4822993A AU683423B2 AU 683423 B2 AU683423 B2 AU 683423B2 AU 48229/93 A AU48229/93 A AU 48229/93A AU 4822993 A AU4822993 A AU 4822993A AU 683423 B2 AU683423 B2 AU 683423B2
Authority
AU
Australia
Prior art keywords
pregna
composition according
methyl
implant
dien
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU48229/93A
Other languages
English (en)
Other versions
AU4822993A (en
Inventor
Elsimar Coutinho
Michel Lanquetin
Jacques Paris
Jean Louis Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Publication of AU4822993A publication Critical patent/AU4822993A/en
Application granted granted Critical
Publication of AU683423B2 publication Critical patent/AU683423B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Steroid Compounds (AREA)
AU48229/93A 1992-09-21 1993-09-17 Subcutaneous implants based on nomegestrol derivatives Ceased AU683423B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
FR9211422 1992-09-21
PCT/FR1993/000900 WO1994006437A1 (fr) 1992-09-21 1993-09-17 Implants sous-cutanes a base de derives de nomegestrol

Publications (2)

Publication Number Publication Date
AU4822993A AU4822993A (en) 1994-04-12
AU683423B2 true AU683423B2 (en) 1997-11-13

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48229/93A Ceased AU683423B2 (en) 1992-09-21 1993-09-17 Subcutaneous implants based on nomegestrol derivatives

Country Status (31)

Country Link
US (1) US5565443A (en, 2012)
EP (1) EP0613372B1 (en, 2012)
JP (1) JPH08506318A (en, 2012)
KR (1) KR100255700B1 (en, 2012)
CN (1) CN1095667C (en, 2012)
AP (1) AP497A (en, 2012)
AT (1) ATE198275T1 (en, 2012)
AU (1) AU683423B2 (en, 2012)
BG (1) BG62317B1 (en, 2012)
BR (1) BR9305642A (en, 2012)
CA (1) CA2122827A1 (en, 2012)
CZ (1) CZ284806B6 (en, 2012)
DE (1) DE69329790D1 (en, 2012)
DZ (1) DZ1717A1 (en, 2012)
EC (1) ECSP930986A (en, 2012)
FI (1) FI942272L (en, 2012)
FR (1) FR2695826B1 (en, 2012)
HU (1) HUT67044A (en, 2012)
IL (1) IL107039A (en, 2012)
MA (1) MA22978A1 (en, 2012)
NO (1) NO306238B1 (en, 2012)
OA (1) OA09924A (en, 2012)
PL (1) PL176120B1 (en, 2012)
RO (1) RO115783B1 (en, 2012)
RU (1) RU2120797C1 (en, 2012)
SK (1) SK54694A3 (en, 2012)
TN (1) TNSN93104A1 (en, 2012)
TW (1) TW381024B (en, 2012)
WO (1) WO1994006437A1 (en, 2012)
YU (1) YU60493A (en, 2012)
ZA (1) ZA936964B (en, 2012)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
GB2355728A (en) * 1999-10-27 2001-05-02 Anson Medical Ltd Tubular medical implants and methods of manufacture
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
EP1323431B1 (en) 2000-08-03 2010-10-27 Antares Pharma IPL AG Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
JP4490095B2 (ja) 2001-06-29 2010-06-23 メドグラフト マイクロテック インコーポレイテッド 生体分解性の注入可能な移植物およびそれに関連する製造方法ならびに使用方法
AU2003240493B2 (en) * 2002-05-31 2008-06-12 L. Molteni & C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. Implantable polymeric device for sustained release of buprenorphine
US20050031667A1 (en) 2003-03-31 2005-02-10 Patel Rajesh A. Implantable polymeric device for sustained release of dopamine agonist
WO2004110400A2 (en) * 2003-05-30 2004-12-23 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of nalmefene
JP5619337B2 (ja) 2003-10-10 2014-11-05 フェリング ビー．ブイ． 皮膚残渣を最小限に抑えるための経皮的医薬製剤
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
PT1781264E (pt) 2004-08-04 2013-10-16 Evonik Corp Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
FR2904213B1 (fr) * 2006-07-27 2008-10-10 Creaspine Soc Par Actions Simp Implant intervertebral destine a la fusion osseuse
ES2718612T3 (es) 2007-12-20 2019-07-03 Evonik Corp Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.

Also Published As

Publication number Publication date
BG62317B1 (bg) 1999-08-31
KR100255700B1 (ko) 2000-08-01
BR9305642A (pt) 1996-01-09
FI942272A7 (fi) 1994-05-16
CZ284806B6 (cs) 1999-03-17
EP0613372A1 (fr) 1994-09-07
US5565443A (en) 1996-10-15
IL107039A (en) 1999-01-26
ATE198275T1 (de) 2001-01-15
AP497A (en) 1996-05-28
NO306238B1 (no) 1999-10-11
OA09924A (fr) 1994-09-15
FI942272A0 (fi) 1994-05-16
IL107039A0 (en) 1993-12-28
YU60493A (sh) 1997-01-08
TNSN93104A1 (fr) 1994-03-17
CA2122827A1 (fr) 1994-03-31
HUT67044A (en) 1995-01-30
ZA936964B (en) 1994-04-14
HU9401395D0 (en) 1994-08-29
BG98776A (bg) 1995-02-28
FR2695826A1 (fr) 1994-03-25
EP0613372B1 (fr) 2000-12-27
CN1094284A (zh) 1994-11-02
AP9300576A0 (en, 2012) 1993-10-31
PL176120B1 (pl) 1999-04-30
FR2695826B1 (fr) 1995-01-06
ECSP930986A (es) 1994-04-12
DZ1717A1 (fr) 2002-02-17
SK54694A3 (en) 1994-10-05
CZ116494A3 (en) 1995-03-15
NO941900D0 (no) 1994-05-20
TW381024B (en) 2000-02-01
JPH08506318A (ja) 1996-07-09
NO941900L (no) 1994-05-24
WO1994006437A1 (fr) 1994-03-31
RO115783B1 (ro) 2000-06-30
MA22978A1 (fr) 1994-04-01
FI942272L (fi) 1994-05-16
DE69329790D1 (de) 2001-02-01
AU4822993A (en) 1994-04-12
CN1095667C (zh) 2002-12-11
RU2120797C1 (ru) 1998-10-27

Similar Documents

Publication Publication Date Title
AU683423B2 (en) Subcutaneous implants based on nomegestrol derivatives
US8865200B2 (en) Sustained release compositions containing progesterone receptor modulators
US4346709A (en) Drug delivery devices comprising erodible polymer and erosion rate modifier
US4155991A (en) Vaginal ring
US4012496A (en) Vaginal ring
AU618052B2 (en) Topical preparations containing danazol
US5733565A (en) Male contraceptive implant
US20090142313A1 (en) Vaginal delivery system
IL116433A (en) INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
JP2001524124A (ja) テストステロンおよびテストステロン前駆体の投与のための膣内薬物送達用具
Yu et al. Metabolic changes in women using a long-acting monthly oral contraceptive and return of ovulation on discontinuation
Nash et al. Patent: Intravaginal ring
Benagiano et al. Long Acting Polydimethylsiloxane Implants for Contraception

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired